Brainstorm Cell Therapeutics announces 1-for-15 reverse stock split effective Sept 30

BRAINSTORM CELL THERAPEUTICS INC.

Board approved 1-for-15 reverse stock split on Sept 23, 2024; stockholders authorized at Sept 16 meeting.
Reverse split effective at 11:59 p.m. ET on Sept 30, 2024; trading on split-adjusted basis Oct 1 under BCLI.
No fractional shares issued; cash in lieu based on closing price prior to effective time.
New CUSIP number 10501E 300; par value unchanged at $0.00005 per share.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.